Clinical Trial Summary Result Information

Clinical trial summary result Information from completed trials in the English-language are available below and on TakedaClinicalTrials.com

If you are a patient, physician, or researcher seeking more information about Takeda's completed clinical trials in the Japanese language please click here.


Search

C13004

Phase 2, Multiple Dose, Open-Label Study to Determine the Long Term Safety of MLN0002 in Patients With Ulcerative Colitis and Crohn's Disease
www.clinicaltrials.gov/ct2/show/NCT00619489

Febuxostat (C02-009)

A Phase 3, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout.
clinicaltrials.gov/ct2/show/NCT00174915

TAK-390MR (T-GD04-082)

A Phase 3 Study to Evaluate the Efficacy and Safety of Dexlansoprazole MR (60 mg Once-Daily (QD) and 90 mg QD) Compared to Placebo on Symptom Relief in Subjects With Symptomatic Non-Erosive Gastroesop...
clinicaltrials.gov/ct2/show/NCT00251745

Alogliptin (SYR-322-SULF-007)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With a Sulfonylurea in Subjects With Type 2 Diabe...
clinicaltrials.gov/ct2/show/results/NCT00286468

Alogliptin (SYR-322-INS-011)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With Insulin in Subjects With Type 2 Diabetes
clinicaltrials.gov/ct2/show/results/NCT00286429

TAK-491_301

A Double-Blind, Randomized, Parallel-Group Study to Compare the Efficacy and Safety of TAK-491 With Valsartan in Subjects With Essential Hypertension
clinicaltrials.gov/ct2/show/results/NCT00591578

TAK-491(01-06-TL-491-019)

A Double-Blind, Randomized, Placebo-Controlled, 5-Arm Titration Study to Evaluate the Efficacy and Safety of TAK-491 When Compared With Valsartan and Olmesartan in Subjects With Essential Hypertension...
clinicaltrials.gov/ct2/show/results/NCT00696436

TAK-491(01-05-TL-491-008)

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 in Subjects With Essential Hypertension
clinicaltrials.gov/ct2/show/results/NCT00696241